A-share review | The Shanghai Index rose 0.31%, Pharmaceutical Biology led the way, Science and Innovation 50 fell 2.51%

The Zhitong Finance App learned that on September 30, the trend of the three major A-share indices diverged after collectively opening higher. The Shanghai Index fluctuated narrowly and closed in popularity, and Science Innovation 50 led the decline. The market showed a pattern of index fragmentation, with individual stocks falling more and less, and pre-holiday trading continued to be light. At the close, the Shanghai Index reported 3842.19 points, up 0.31%; Shenzhen Stock Exchange reported 12887.62 points, down 0.11%; GEM reported 3135.28 points, down 0.23%; Science and Innovation 50 reported 1530.01 points, down 2.51%; and Beijing Securities 50 reported 1039.61 points, up 0.70%. The turnover of the Shanghai and Shenzhen markets was 1437.989 billion yuan, an increase of 28.792 billion yuan over the previous trading day. Shanghai and Shenzhen A shares (excluding the Beijing Stock Exchange) rose 2,567 individual stocks, 2,824 stocks fell, and 181 traded flat. Of these, 56 rose or stopped and 13 fell to a standstill, accounting for about 46% of the rising stocks. In terms of sectors, biological products, medical services, implants, chemical pharmaceuticals, commercial vehicles, and liquor registered the highest gains; semiconductors, memories, advanced packaging, HBM, electronic chemicals, and components registered the highest declines.

Drivers

The market on the same day consists of several verifiable information: First, the index was clearly differentiated. The Shanghai Index rose 0.31%, the Beijing Stock Exchange 50 rose 0.70%, the Shenzhen Stock Exchange Index fell 0.11%, the GEM Index fell 0.23%, the Science and Innovation 50 fell 2.51%. The turnover of the Shanghai and Shenzhen markets was 1437.989 billion yuan, with an increase of 28.792 billion yuan over the previous trading day, accounting for about 46%; Second, the National Bureau of Statistics announced on September 30 that the September manufacturing purchasing managers' index was 50.1%, up 0.3 percentage points from the previous month, ending two consecutive months below the boom and bust line, repeat In the expansion range, the index of non-manufacturing business activity during the same period was 50.2%, up 1.2 percentage points from the previous month; third, on September 29, intensive external licensing transactions were implemented. AstraZeneca announced that it would invest 2 billion US dollars in strategic equity investment in Summit and lead clinical research on related combination therapies. On the same day, Hengrui Pharmaceutical announced that HRS-1596 was licensed to Novo Nordisk for global development, production and commercialization rights outside mainland China, Hong Kong, Macau, and Taiwan, China, with a potential total transaction volume of up to 2.6 billion US dollars (the pipeline is metabolic and metabolic reduction) (Focus direction, different from the cancer treatment line); Fourth, the Ministry of Finance, together with the People's Bank of China and the General Administration of Financial Supervision, issued the “Notice on Implementing the Interest Rate Discount Policy for Residential Home Purchase Loans” (Finance (2026) No. 95) on September 29. Starting October 1, the real estate industry index closed up 0.67% on the same day; Fifth, the National Climate Center expects El Niño to peak around November this year and the sea temperature index will be 1 percentage point annualized for a maximum period of 5 years. 3.2℃ to 3.5℃, forming the strongest super El Niño event since monitoring records were recorded.

Popular sector aspects

1. The [Pharmaceutical Biology] sector was the strongest main line of the day. The tumor vaccine concept index closed up 9.67%, CRO closed up 3.79%, the biological products industry index closed up 4.18%, medical services closed up 3.86%, and chemical pharmaceuticals closed up 2.79%. In terms of individual stocks, Cansino rose and stopped 20CM (+20.00%), Tylomaebo-U 20CM (+19.99%), Nanmo Biotech rose 19.87%, Biopsis rose 14.69%, nearshore protein rose 13.47%, Zhaoyuan Pharmaceutical (+10.00%), Kangchen Pharmaceutical (+10.00%), Nanhua Biotech (+10.01%), and Osecon (+9.98%) rose and stopped. On the catalytic side, US stock Moderna (Moderna) closed above $203 and hit a new 52-week high, providing the sector with the most direct emotional transmission; AstraZeneca announced on September 29 that it would invest 2 billion US dollars in strategic equity investment in Summit and lead clinical research on combination therapies such as Evarich and CLDN18.2 ADC; Hengrui Pharmaceutical announced on the same day that HRS-1596 overseas rights will be licensed to Novo Nordisk, with a potential total transaction amount of up to 2.6 billion US dollars; in addition, phase III clinical data related to mRNA cancer vaccines will be held in October Announced at the 2026 European Society of Medical Oncology (ESMO) Congress.

2. The [Planting and Agriculture] industry index closed up 3.72%, the sugar concept closed up 3.28%, the corn (+2.18%) and genetically modified (+2.53%) concepts strengthened simultaneously, Hainan rubber rose and stopped (+10.02%), Denghai seed industry rose and stopped (+10.00%), and Wanxiang Denong rose 5.22%. In terms of catalysis, the China Meteorological Administration reported at its September 29 press conference that the National Climate Center expects El Niño to peak around November this year, with a sea temperature index of 3.2°C-3.5℃, forming the strongest super El Niño event since monitoring records were recorded. At the same time, it also suggests that the impact on agricultural production is regional and seasonal, and is often more prominent the following year.

3. [Commercial Vehicles/General Equipment and Robots] The commercial vehicle industry index closed up 2.57%, JAC rose 5.49%, and Dongfeng shares rose 2.69%; in the auto parts direction, Songzhi shares rose and stopped (+10.00%); in the robotics and general equipment direction, Ningbo Dongli (+10.04%) and Longxi shares (+9.98%) rose and stopped (both of the Shenwan industries are mechanical equipment, belonging to the “robot concept” and “humanoid robot” component stocks), and Xiangyang Bearing (+9.98%) broke out of the 4-game series (+9.98%). %, then block the rise and stop). On the catalytic side, according to news from the Financial Federation on September 30, Yu Chengdong, executive director of Huawei, said a few days ago that the new Zunjie SUV in collaboration between Huawei and JAC is expected to be launched in early 2027. Furthermore, the solid-state battery direction continues to be active, with Shanghai Xiba (+10.01%) and Chuanyi Technology (+10.03%) joining the board.

Adjust the section

The semiconductor industry chain and the electronics sector, which was active on the previous trading day, had the highest declines on the same day: the semiconductor industry index closed down 2.99%, memory concepts closed down 2.74%, advanced packaging (-2.42%), HBM (-3.12%), and electronic chemicals (-2.39%) declined simultaneously. In terms of individual stocks, VeriSilicon shares fell 11.34%, Kangqiang Electronics fell 8.74% (once halted during the intraday period). Huafeng Measurement and Control fell 6.26%, SMIC fell 4.70%, and Cambrian fell 3.54%. The component industry index, which closed up 2.51% on the previous trading day, closed down 2.60% on the same day, and the decline in the printed circuit board direction was also the highest.